Pietragallo Gordon Alfano Bosick & Raspanti, LLP
Prostaglandin E1 and E2 analogs for the treatment of various medical conditions
A prostaglandin analog with selectivity to EP receptors and demonstrating EP agonist activity that may be used to expand hematopoietic stem cell populations or to treat or prevent influenza, bone fracture, bone disease, glaucoma, ocular hypertension, dysmenorrhoea, pre-term labor, immune disorders, osteoporosis, asthma, allergy, male sexual dysfunction, female sexual dysfunction, periodontal disease, gastric ulcer, renal disease, or other EP receptor-mediated conditions.
Cayman Chemical Company, Incorporated
C A
C07C A61P
inventional inventional
Stephen D. Nancy S. Adam Kirk M. Andriy M. Gregory W.
Barrett Barta Uzieblo Maxey Kornilov Endres